S. Füssel

1.9k total citations
57 papers, 1.4k citations indexed

About

S. Füssel is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, S. Füssel has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 19 papers in Pulmonary and Respiratory Medicine and 17 papers in Oncology. Recurrent topics in S. Füssel's work include Prostate Cancer Treatment and Research (10 papers), Renal cell carcinoma treatment (8 papers) and Immunotherapy and Immune Responses (8 papers). S. Füssel is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Renal cell carcinoma treatment (8 papers) and Immunotherapy and Immune Responses (8 papers). S. Füssel collaborates with scholars based in Germany, United States and United Kingdom. S. Füssel's co-authors include Manfred P. Wirth, Axel Meye, Marc Schmitz, Andrea Kießling, Ralph de Vere White, Thorsten Schlomm, Anders Bjartell, Lourdes Mengual, Tapio Visakorpi and Freddie C. Hamdy and has published in prestigious journals such as PLoS ONE, Biochemistry and Oncogene.

In The Last Decade

S. Füssel

56 papers receiving 1.4k citations

Peers

S. Füssel
Jacson Shen United States
Edwardine Labay United States
Bo Su China
Eric A. Murphy United States
Jacson Shen United States
S. Füssel
Citations per year, relative to S. Füssel S. Füssel (= 1×) peers Jacson Shen

Countries citing papers authored by S. Füssel

Since Specialization
Citations

This map shows the geographic impact of S. Füssel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Füssel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Füssel more than expected).

Fields of papers citing papers by S. Füssel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Füssel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Füssel. The network helps show where S. Füssel may publish in the future.

Co-authorship network of co-authors of S. Füssel

This figure shows the co-authorship network connecting the top 25 collaborators of S. Füssel. A scholar is included among the top collaborators of S. Füssel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Füssel. S. Füssel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Grützmann, Konrad, Karsten Salomo, Alexander Krüger, et al.. (2024). Identification of novel snoRNA-based biomarkers for clear cell renal cell carcinoma from urine-derived extracellular vesicles. Biology Direct. 19(1). 38–38. 10 indexed citations
3.
Thomas, Christian, Martin Baunacke, Holger H.H. Erb, et al.. (2021). Systemic Triple Therapy in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Ready for Prime Time or Still to Be Explored?. Cancers. 14(1). 8–8. 11 indexed citations
4.
Hampel, Silke, et al.. (2017). Systematic evaluation of oligodeoxynucleotide binding and hybridization to modified multi-walled carbon nanotubes. Journal of Nanobiotechnology. 15(1). 53–53. 7 indexed citations
5.
Toma, Marieta, Rebekka Wehner, Georgia Fodelianaki, et al.. (2015). Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis. OncoImmunology. 4(6). e1008342–e1008342. 16 indexed citations
6.
Becker, Frank, Kerstin Junker, Arndt Hartmann, et al.. (2013). Collecting Duct Carcinomas Represent a Unique Tumor Entity Based on Genetic Alterations. PLoS ONE. 8(10). e78137–e78137. 27 indexed citations
7.
Nawroth, Roman, Arndt Hartmann, P. Olbert, et al.. (2011). Blasenkarzinom – Update: Was gab es neues auf dem Jahreskongress 2010 der Deutschen Gesellschaft für Urologie in Düsseldorf?. RWTH Publications (RWTH Aachen). 50(2). 221–226. 1 indexed citations
8.
Kotzsch, Matthias, Viktor Magdolen, Thomas Greither, et al.. (2011). Combined mRNA expression levels of members of the urokinase plasminogen activator (uPA) system correlate with disease-associated survival of soft-tissue sarcoma patients. BMC Cancer. 11(1). 273–273. 11 indexed citations
9.
Catto, James W.F., Antonio Alcaraz, Anders Bjartell, et al.. (2011). MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review. European Urology. 59(5). 671–681. 369 indexed citations
10.
Füssel, S., et al.. (2010). Klinischer Behandlungspfad – konservative Wirbelsäulenbehandlung. Der Orthopäde. 39(8). 764–770. 1 indexed citations
11.
Matussek, J., et al.. (2010). Orthesenversorgung bei Osteoporose und osteoporotischen Wirbelkörperfrakturen. Der Orthopäde. 39(4). 387–396. 6 indexed citations
12.
Füssel, S., Andrea Kießling, Rebekka Wehner, et al.. (2010). Dendritic Cell‐Based Immunotherapy for Prostate Cancer. Journal of Immunology Research. 2010(1). 517493–517493. 71 indexed citations
13.
Täubert, Helge, Peter Würl, Thomas Greither, et al.. (2010). Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patients. British Journal of Cancer. 102(4). 731–737. 39 indexed citations
14.
Taylor, Arthur, Kamil Lipert, Kai Krämer, et al.. (2009). Biocompatibility of Iron Filled Carbon Nanotubes <I>In Vitro</I>. Journal of Nanoscience and Nanotechnology. 9(10). 5709–5716. 21 indexed citations
15.
Kießling, Andrea, S. Füssel, Rebekka Wehner, et al.. (2007). Advances in Specific Immunotherapy for Prostate Cancer. European Urology. 53(4). 694–708. 44 indexed citations
16.
Krämer, Klaus, Axel Meye, A. Taylor, et al.. (2007). Multifunktionale Kohlenstoffnanoröhren für biomedizinsche Anwendungen (CARBIO). Der Urologe. 46(9). 1248–1248. 1 indexed citations
17.
Förster, Yvonne, Axel Meye, Sybille Albrecht, et al.. (2003). Tissue specific expression and serum levels of human tissue factor in patients with urological cancer. Cancer Letters. 193(1). 65–73. 24 indexed citations
18.
Kießling, Andrea, S. Füssel, Marc Schmitz, et al.. (2003). Identification of an HLA‐A*0201‐restricted T‐cell epitope derived from the prostate cancer‐associated protein trp‐p8. The Prostate. 56(4). 270–279. 45 indexed citations
19.
Kießling, Andrea, Marc Schmitz, Stefan Stevanović, et al.. (2002). Prostate stem cell antigen: Identification of immunogenic peptides and assessment of reactive CD8+ T cells in prostate cancer patients. International Journal of Cancer. 102(4). 390–397. 61 indexed citations
20.
Schmidt, U., Ulrike Fiedler, Christian Pilarsky, et al.. (2001). Identification of a novel gene on chromosome 13 between BRCA‐2 and RB‐1. The Prostate. 47(2). 91–101. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026